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Water channels in health and disease
The last ten years have witnessed major advances in the
understanding of the cellular action of vasopressin and the
pathogenesis of disorders of water balance. The cloning of the
vasopressin receptors and of a family of water channels have been
central to these advances. These two proteins constitute the
initiating and culminating steps in the hydroosmotic effect of the
hormone in the mammalian collecting tubule. Specifically, water
transport across this epithelium, whose water permeability is very
low in the basal state, is triggered by the binding of vasopressin to
the V2 receptor on the basolateral membrane. This binding is
coupled to the heterotrimeric G protein Gs that leads to the
generation of the hormone’s second messenger cAMP. The cyclic
nucleotide in turn activates the cyclic nucleotide dependent kinase
(PKA). In contrast to other members of the water channel family,
one of them (AQP-2), is uniquely expressed in the collecting duct,
the vasopressin sensitive segment of the nephron [1]. The hy-
droosmotic effect of the hormone occurs very promptly. It is
therefore not surprising that vasopressin is involved in the short-
term regulation of AQP-2 action. This occurs by the insertion of
the water channels from subapical vesicles into the apical mem-
brane, most likely by a cAMP dependent phosphorylation of the
water channel protein [2]. Vasopressin is also involved in the
longer term regulation of AQP-2 synthesis. The expression of the
protein is markedly decreased in the absence of the hormone as
revealed in rats with congenital central diabetes insipidus, and is
then restored after several days of vasopressin administration [3].
However, a vasopressin independent regulation of AQP-2 expres-
sion is also operant, as in the setting of vasopressin escape the
protein is down-regulated despite continuous administration of
the hormone [4].
Disorders in the V2 receptor and aquaporin appear to underlie
or to be associated with a number of disorders of water balance.
Specifically, it is now well established that the x-linked form of
congenital nephrogenic diabetes insipidus is caused by a variety of
mutations in the V2 receptor [5]. The expression of V2 has not
been systematically examined in most states associated with
disturbances of water metabolism. However, in a model of chronic
renal failure that is known to be associated with hormone
resistance, the transcription of V2 receptor mRNA is decreased
[6].
Considerably more interest has focused on the association
between disturbances in water balance and alterations in water
channels. Thus, a rare form of congenital nephrogenic diabetes
insipidus that is inherited as an autosomal recessive trait is due to
mutation in the AQP-2 molecule that renders it non-functional.
Likewise, the expression of AQP-2 has been examined in several
models of acquired nephrogenic diabetes insipidus. Thus, in
polyuric lithium treated rats [7] AQP-2 is down-regulated in the
medulla, while in hypokalemic rats AQP-2 expression is decreased
in both the cortex and medulla [8]. A similar down-regulation
occurs in protein deprived rats [9], but is limited to the terminal
inner medulla. It must be noted that in most of the pathophysio-
logic settings described above, a defect in the generation of cAMP
has been well established. Since cAMP is involved in the tran-
scriptional regulation of AQP-2 [10], it is possible that the
down-regulation of AQP-2 expression is a consequence of this
process and not the primary cause of vasopressin resistance.
The role of AQP-2 has also been examined in water retaining
states frequently associated with high circulating levels of vaso-
pressin. In this regard, the expression of AQP-2 has been reported
to be elevated in animals with heart failure [11] as well as in
cirrhotic rats [12]. It is of interest that in both of these studies an
oral antagonist of the V2 receptor (OPC31260) was associated
with a reversal of the up-regulation of the AQP-2 expression,
suggesting again that it is not vasopressin per se but rather a V2
receptor-mediated function, most likely the generation of cAMP,
that regulates the protein’s synthesis. In contrast, studies in
another model of sodium and water retention, namely the rat with
nephrotic syndrome, have yielded a different result. The study
published in this issue of Kidney International employing adriamy-
cin [13], as well as a previous study by the same group employing
puromycin aminonucleoside to cause the nephrotic syndrome
[14], have both noted a decrease rather than the expected increase
in AQP-2 expression. The decrease is not limited to AQP-2 as it
is shared not only with other water channels expressed in the
collecting duct (AQP-3 and AQP-4) and to a lesser degree by
AQP-1, a water channel expressed in the proximal tubule and
descending limb of Henle but also with the urea transporter in the
inner medulla. The significance of this widespread decrement in
transporting proteins vis-a-vis the tubular handling of sodium and
water in this model remains speculative. Whether a similar
decrement also affects sodium transporting proteins would be of
interest to explore. Nor is it obvious what factors make this
sodium and water retaining model different from the others
described above. Glomerular filtration rate, as assessed by creat-
inine clearance, was not statistically decreased in the nephrotic
rats. Nonetheless, a 40% decrement in creatinine clearance was
noted. Whether such a change in renal function alters AQP-2
expression has not been studied. It appears, however, likely that
the decrease in Gsa and adenylyl cyclase VI observed in the model
culminates in a decreased cAMP generation, and is responsible at
least in part for the observed decrease in AQP-2. Alternatively,
the observed down-regulation of the water channels and perhaps
of the urea transporter could be a consequence of ECF volume
expansion. Contrary to the classic view that edema formation and
sodium retention in the nephrotic syndrome are associated with
hypovolemia, there is increasing evidence for volume expansion in
such patients and not only in those with abnormal renal histology
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and function, but also in those with minimal change disease. In
models of escape from vasopressin antidiuresis, the down-regula-
tion of AQP-2 expression is critically dependent on the mainte-
nance of volume expansion [15]. A similar process may be operant
in the nephrotic syndrome. Finally, the mechanism by which
volume expansion leads to the decrement in the synthesis of
several water and solute transporting proteins will require further
investigation.
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